We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+14.7%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$26.8B
AUM Growth
+$2.91B
(+12%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
30.26%
Holding
2,338
New
416
Increased
946
Reduced
559
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$80.5M |
| 2 |
Netflix
NFLX
|
+$48M |
| 3 |
Broadcom
AVGO
|
+$47.1M |
| 4 |
Palantir
PLTR
|
+$44.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$62.2M |
| 2 |
Global Payments
GPN
|
+$50.1M |
| 3 |
Honeywell
HON
|
+$31.1M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$30.5M |
| 5 |
Medtronic
MDT
|
+$30.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.25% |
| 2 | Financials | 14.66% |
| 3 | Consumer Discretionary | 9.77% |
| 4 | Communication Services | 9.36% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
DNOW Inc
DNOW
$2.63B
| $752K | ﹤0.01% |
50,700
+1,900
| +4% | +$29K |
|
1027
Knowles
KN
$3.22B
| $751K | ﹤0.01% |
42,600
-1,100
| -3% | -$17.8K |
|
1028
Tarsus Pharmaceuticals
TARS
$2.56B
| $749K | ﹤0.01% |
18,500
+12,900
| +230% | +$581K |
|
1029
Diebold Nixdorf
DBD
$3.09B
| $748K | ﹤0.01% |
13,500
-1,300
| -9% | -$61K |
|
|
AKRO
1030
DELISTED
Akero Therapeutics
AKRO
| $747K | ﹤0.01% |
14,000
+1,400
| +11% | +$63.6K |
|
1031
Archer Aviation
ACHR
$3.64B
| $746K | ﹤0.01% |
68,800
+65,000
| +1,711% | +$608K |
|
1032
Universal Technical Institute
UTI
$2.08B
| $746K | ﹤0.01% |
22,000
+10,100
| +85% | +$317K |
|
1033
Flywire
FLYW
$1.96B
| $737K | ﹤0.01% |
63,000
-2,300
| -4% | -$23.4K |
|
1034
Brown & Brown
BRO
$22.9B
| $730K | ﹤0.01% |
+6,587
| New | +$740K |
|
1035
Benchmark Electronics
BHE
$2.91B
| $730K | ﹤0.01% |
18,800
+1,000
| +6% | +$36.6K |
|
1036
Limbach Holdings
LMB
$867M
| $729K | ﹤0.01% |
5,200
-1,000
| -16% | -$114K |
|
1037
Pediatrix Medical
MD
$2.16B
| $726K | ﹤0.01% |
50,600
+3,000
| +6% | +$41.1K |
|
1038
Enerpac Tool Group
EPAC
$1.77B
| $726K | ﹤0.01% |
17,900
-2,500
| -12% | -$105K |
|
1039
International Seaways
INSW
$4.57B
| $726K | ﹤0.01% |
19,900
+300
| +2% | +$10.8K |
|
1040
10x Genomics
TXG
$5.87B
| $725K | ﹤0.01% |
+62,600
| New | +$571K |
|
1041
Worthington Steel
WS
$1.8B
| $725K | ﹤0.01% |
24,300
+1,200
| +5% | +$30.9K |
|
1042
Gartner
IT
$9.41B
| $724K | ﹤0.01% |
+1,791
| New | +$749K |
|
1043
ABM Industries
ABM
$2.8B
| $722K | ﹤0.01% |
15,300
-5,900
| -28% | -$285K |
|
1044
Lindsay Corp
LNN
$1.16B
| $721K | ﹤0.01% |
+5,000
| New | +$668K |
|
1045
A10 Networks
ATEN
$2.47B
| $720K | ﹤0.01% |
37,200
-1,500
| -4% | -$25.6K |
|
1046
American Superconductor
AMSC
$1.48B
| $719K | ﹤0.01% |
19,600
-1,300
| -6% | -$32K |
|
|
CSW
1047
CSW Industrials
CSW
$4.71B
| $717K | ﹤0.01% |
2,500
-2,000
| -44% | -$604K |
|
1048
HCI Group
HCI
$2.28B
| $715K | ﹤0.01% |
+4,700
| New | +$722K |
|
|
MRX
1049
Marex Group Limited Ordinary Shares
MRX
$4.72B
| $714K | ﹤0.01% |
+18,100
| New | +$753K |
|
1050
Federal Signal
FSS
$7.25B
| $713K | ﹤0.01% |
6,700
+1,400
| +26% | +$125K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2025 Portfolio in Review
As of Q2 2025, STRS Ohio held 2,338 positions worth $26.8B, up 12% from $23.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
STRS Ohio's Q2 2025 filing shows 416 new, 946 increased, 559 reduced and 143 closed positions. Its largest new stake was Rockwell Automation: 97,205 shares worth $32.3M. The largest sale was Progressive, an estimated $62.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- STRS Ohio's largest Q2 2025 buy was Rockwell Automation: 97,205 shares worth $32.3M.
- STRS Ohio added most to Microsoft in Q2 2025, an estimated $80.5M increase.
- STRS Ohio's biggest Q2 2025 reduction was Progressive, cutting an estimated $62.2M.
- STRS Ohio fully exited AstraZeneca in Q2 2025, selling an estimated $26.8M.
- STRS Ohio's ten largest holdings make up 30% of its $26.8B portfolio in Q2 2025.
- STRS Ohio opened 416 new positions and closed 143 in Q2 2025.
- STRS Ohio's portfolio value rose 12% quarter-over-quarter to $26.8B.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.